Molecular genetics of congenital heart disease

Xiaoqing Zhang1,2, Ming Qi1,2, Qihua Fu3,4,5

  • 1Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.

PubMed

Insights

Congenital heart disease (CHD) is a common birth defect. Genetic factors, including mutations and chromosomal issues, are increasingly identified as key causes, impacting CHD research and treatment.

Area of Science:

  • Genetics
  • Pediatrics
  • Cardiology

Background:

  • Congenital heart disease (CHD) is the most common birth defect and a major cause of childhood mortality.
  • Despite improved interventions, survivors often face significant comorbidities impacting quality of life.
  • The causes of CHD are multifactorial, involving genetic and environmental influences, with many cases remaining unexplained.

Purpose of the Study:

  • To provide an updated review of the genetic factors contributing to CHD.
  • To summarize recent advancements in identifying genetic causes of CHD.
  • To discuss the role of non-coding mutations and complex inheritance in CHD etiology.

Main Methods:

  • Literature review of recent advancements in genetic testing technologies for CHD.
  • Synthesis of established genetic contributions, including chromosomal aberrations and gene mutations.
  • Discussion of emerging findings on non-coding mutations and complex inheritance patterns.

Main Results:

  • Genetic testing has enhanced the identification of CHD causes.
  • Established genetic factors include mutations in transcription factors, cardiac proteins, chromatin modifiers, cilia proteins, and signaling pathways.
  • Recent research highlights the significance of non-coding mutations and complex genetic inheritance.

Conclusions:

  • Genetic factors play a substantial role in the etiology of congenital heart disease.
  • Continued research into genetic and epigenetic factors is crucial for understanding and managing CHD.
  • Advancements in genetic analysis offer improved diagnostic capabilities and potential therapeutic targets for CHD.